COO of Amicus Therapeutics Inc (30-Year Financial, Insider Trades) Bradley L Campbell (insider trades) sold 24,783 shares of FOLD on 12/01/2020 at an average price of $22.77 a share. The total sale was $564,309.
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines. Amicus Therapeutics Inc has a market cap of $6.05 billion; its shares were traded at around $23.23 with and P/S ratio of 24.32.
CEO Recent Trades:
- Chairman & CEO John F Crowley sold 7,500 shares of FOLD stock on 12/01/2020 at the average price of $22.77. The price of the stock has increased by 2.02% since.
Directors and Officers Recent Trades:
- COO Bradley L Campbell sold 24,783 shares of FOLD stock on 12/01/2020 at the average price of $22.77. The price of the stock has increased by 2.02% since.
- Principal Accounting Officer Samantha Prout sold 5,931 shares of FOLD stock on 11/04/2020 at the average price of $20. The price of the stock has increased by 16.15% since.
For the complete insider trading history of FOLD, click here
.
